192 related articles for article (PubMed ID: 12107041)
1. Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems?
De Wildt WA; Schippers GM; Van Den Brink W; Potgieter AS; Deckers F; Bets D
Alcohol Alcohol; 2002; 37(4):375-82. PubMed ID: 12107041
[TBL] [Abstract][Full Text] [Related]
2. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
[TBL] [Abstract][Full Text] [Related]
3. Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study.
Soyka M; Preuss U; Schuetz C
Drugs R D; 2002; 3(1):1-12. PubMed ID: 11881521
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of compliance therapy in pharmacotherapy for alcohol dependence: a randomized controlled trial.
Reid SC; Teesson M; Sannibale C; Matsuda M; Haber PS
J Stud Alcohol; 2005 Nov; 66(6):833-41. PubMed ID: 16459945
[TBL] [Abstract][Full Text] [Related]
5. Cognitive behavioural therapy combined with the relapse-prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence improved?
Feeney GF; Young RM; Connor JP; Tucker J; McPherson A
Aust N Z J Psychiatry; 2002 Oct; 36(5):622-8. PubMed ID: 12225445
[TBL] [Abstract][Full Text] [Related]
6. The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial.
Wölwer W; Frommann N; Jänner M; Franke PE; Scherbaum N; Lieb B; Falkai P; Wobrock T; Kuhlmann T; Radermacher M; Maier W; Schütz C; Ohmann C; Burtscheidt W; Gaebel W
Drug Alcohol Depend; 2011 Nov; 118(2-3):417-22. PubMed ID: 21621929
[TBL] [Abstract][Full Text] [Related]
7. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
[TBL] [Abstract][Full Text] [Related]
8. A comparison of two intensities of psychosocial intervention for alcohol dependent patients treated with acamprosate.
Hammarberg A; Wennberg P; Beck O; Franck J
Alcohol Alcohol; 2004; 39(3):251-5. PubMed ID: 15082464
[TBL] [Abstract][Full Text] [Related]
9. Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes.
Donovan DM; Anton RF; Miller WR; Longabaugh R; Hosking JD; Youngblood M;
J Stud Alcohol Drugs; 2008 Jan; 69(1):5-13. PubMed ID: 18080059
[TBL] [Abstract][Full Text] [Related]
10. A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care.
Kiritzé-Topor P; Huas D; Rosenzweig C; Comte S; Paille F; Lehert P
Alcohol Alcohol; 2004; 39(6):520-7. PubMed ID: 15304381
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.
Berger L; Fisher M; Brondino M; Bohn M; Gwyther R; Longo L; Beier N; Ford A; Greco J; Garbutt JC
Alcohol Clin Exp Res; 2013 Apr; 37(4):668-74. PubMed ID: 23134193
[TBL] [Abstract][Full Text] [Related]
12. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A;
JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409
[TBL] [Abstract][Full Text] [Related]
13. Acamprosate treatment in a long-term community-based alcohol rehabilitation programme.
Poldrugo F
Addiction; 1997 Nov; 92(11):1537-46. PubMed ID: 9519495
[TBL] [Abstract][Full Text] [Related]
14. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
[TBL] [Abstract][Full Text] [Related]
15. [Acamprosate and psychosocial intervention. An integrative treatment approach for prevention of alcohol dependent patients in Switzerland].
Fuchs WJ; Riebenfeld D
Praxis (Bern 1994); 2002 Apr; 91(17):735-42. PubMed ID: 12038194
[TBL] [Abstract][Full Text] [Related]
16. Acamprosate for the treatment of alcohol dependence.
Boothby LA; Doering PL
Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
[TBL] [Abstract][Full Text] [Related]
17. United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol.
Chick J; Howlett H; Morgan MY; Ritson B
Alcohol Alcohol; 2000; 35(2):176-87. PubMed ID: 10787394
[TBL] [Abstract][Full Text] [Related]
18. An open study with acamprosate in Belgium and Luxemburg: results on sociodemographics, supportive treatment and outcome.
Ansoms C; Deckers F; Lehert P; Pelc I; Potgieter A
Eur Addict Res; 2000 Sep; 6(3):132-40. PubMed ID: 11060477
[TBL] [Abstract][Full Text] [Related]
19. Acamprosate in alcohol dependence: how does it work?
Littleton J
Addiction; 1995 Sep; 90(9):1179-88. PubMed ID: 7580816
[TBL] [Abstract][Full Text] [Related]
20. Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study.
Tempesta E; Janiri L; Bignamini A; Chabac S; Potgieter A
Alcohol Alcohol; 2000; 35(2):202-9. PubMed ID: 10787398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
